日本新冠神药又没通过审批 盐野义股价大跌 10%

Wallstreetcn
2022.07.21 00:38

盐野义制药公司股价大跌 10%，此前日本厚生劳动省专门小组第二次暂缓批准其新冠口服药 Xocova。

盐野义制药公司股价大跌 10%，此前日本厚生劳动省专门小组第二次暂缓批准其新冠口服药 Xocova。

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.